Procter & Gamble Co (NYSE:PG) Shares Purchased by Dempze Nancy E

Share on StockTwits

Dempze Nancy E lifted its stake in Procter & Gamble Co (NYSE:PG) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 20,496 shares of the company’s stock after purchasing an additional 300 shares during the quarter. Procter & Gamble comprises about 2.8% of Dempze Nancy E’s holdings, making the stock its 15th largest holding. Dempze Nancy E’s holdings in Procter & Gamble were worth $2,559,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the stock. Lucia Wealth Services LLC purchased a new position in shares of Procter & Gamble during the third quarter worth $29,000. Belmont Capital LLC acquired a new stake in Procter & Gamble in the fourth quarter valued at $34,000. Selective Wealth Management Inc. acquired a new stake in shares of Procter & Gamble during the third quarter worth about $35,000. Princeton Global Asset Management LLC increased its position in shares of Procter & Gamble by 51.4% during the second quarter. Princeton Global Asset Management LLC now owns 442 shares of the company’s stock worth $48,000 after purchasing an additional 150 shares in the last quarter. Finally, Ironwood Financial llc increased its position in shares of Procter & Gamble by 27.3% during the third quarter. Ironwood Financial llc now owns 480 shares of the company’s stock worth $60,000 after purchasing an additional 103 shares in the last quarter. 62.74% of the stock is owned by hedge funds and other institutional investors.

Shares of NYSE:PG opened at $125.96 on Thursday. The business’s 50 day simple moving average is $124.20 and its 200-day simple moving average is $120.41. The firm has a market capitalization of $310.95 billion, a price-to-earnings ratio of 27.87, a price-to-earnings-growth ratio of 3.38 and a beta of 0.40. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.72 and a quick ratio of 0.54. Procter & Gamble Co has a 12 month low of $89.08 and a 12 month high of $126.60.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $1.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.13. The business had revenue of $17.80 billion for the quarter, compared to analyst estimates of $17.43 billion. Procter & Gamble had a return on equity of 25.07% and a net margin of 6.24%. The company’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.12 EPS. On average, equities analysts anticipate that Procter & Gamble Co will post 4.94 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a dividend of $0.7459 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.98 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio is currently 65.93%.

In related news, CEO David S. Taylor sold 50,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $124.01, for a total transaction of $6,200,500.00. Following the completion of the transaction, the chief executive officer now directly owns 277,521 shares in the company, valued at approximately $34,415,379.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Steven D. Bishop sold 41,165 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, October 23rd. The stock was sold at an average price of $123.36, for a total value of $5,078,114.40. Following the transaction, the chief executive officer now owns 45,176 shares of the company’s stock, valued at $5,572,911.36. The disclosure for this sale can be found here. Insiders have sold a total of 1,288,513 shares of company stock valued at $159,734,252 over the last 90 days. Insiders own 1.75% of the company’s stock.

A number of analysts have recently commented on PG shares. Goldman Sachs Group reiterated a “buy” rating and set a $136.00 target price on shares of Procter & Gamble in a research report on Wednesday, October 23rd. UBS Group boosted their price target on Procter & Gamble from $122.00 to $126.00 and gave the company a “neutral” rating in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. boosted their price target on Procter & Gamble from $136.00 to $139.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Macquarie boosted their price target on Procter & Gamble from $132.00 to $138.00 and gave the company an “outperform” rating in a research report on Wednesday, October 23rd. Finally, ValuEngine lowered Procter & Gamble from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $119.07.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Further Reading: Gap Down Stocks

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.